ID - 1501
EFFICACY AND SAFETY OF BELUMOSUDIL VERSUS BEST AVAILABLE THERAPY FOR THE TREATMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE IN THE US POPULATION
K Halla, A Lazaryanb, M Van der Laanc, C Leed, A Logane, S Gruberf, S Kabadig, I Khang, C Nichollsh, L Rotag, E Nikaii, E Ponomarevaj, A Koumasj, EK Wallera
a Emory Winship Cancer Institute, United States
b Moffitt Cancer Center, United States
c University of California; TL Revolution, United States
d Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, United States
e University of California, Helen Diller Family Comprehensive Cancer Center, United States
f TL Revolution, United States
g Sanofi, United States
j Axtria, United States
Ver más
